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Great interest in herbal medicine as a potential source of phytopharmaceuticals has created the need 
to review common factors responsible for major diseases and body disorders. This review shows one 
such common factor in inflammation and the role herbal medicine can play. Traditional medicinal 
herbal remedies in the southern African region have long been used to treat various pain- or 
inflammation-related symptoms. Although the precise mechanisms of action of many herbal drugs 
have yet to be determined, some of them have been shown to exert anti-inflammatory and/or 
antioxidant effects in a variety of cells in the human and animal bodies. There is increasing evidence to 
indicate that both peripheral and central nervous system cells play a prominent role in the chronic 
inflammatory responses in the body system and anti-inflammatory herbal medicine and its 
constituents are being proved to be a potent protector against various pro-inflammatory mediators in 
diseases and disorders. These mediators have therefore been suspected of being the functional basis 
of diseases and disorders. The structural diversity of these medicinal herbs makes them a valuable 
source of novel lead compounds against the therapeutic molecular targets, cytokines and mediators, 
that have been newly discovered by the platforms of genomics, proteomics, metabolomics and high-
throughput technologies. This article reviews the basic mechanisms of inflammation and the potential 
of 123 southern African plant species to be effective as chronic inflammatory disease preventive 
agents. With one third of these species there are no indications of the chemical composition, indicating 
possible subjects for further research. 
 





The molecular mechanism of chronic inflammation, its 
prevention and mitigation with phytomedicines have been 
intensively evaluated by our group over the past ten 
years (McGaw et al., 1997; Eloff et al., 2001; McGaw et 
al., 2001; Iwalewa et al., 2003; Omisore et al., 2004; 
Iwalewa and Agbani, 2004; Iwalewa et al., 2005; Omisore 
et al., 2005; Iwalewa et al., 2006; Idowu et al., 2006; 
Naidoo et al., 2006; Angeh et al., 2007). Epidemiological 
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eases such as atherosclerosis, arthritis, diabetes, acquir-
ed immune deficiency syndrome (AIDS) mediated by the 
Human Immunovirus, asthma, neoplasia, degenerative 
and cardiovascular diseases are associated with frequent 
intake of fruits and vegetables (Ames et al., 1993; Chu et 
al., 2002; Choi et al., 2002). Animal studies have also 
shown biological effects of several naturally occurring 
substances from foods, herbs and other natural sources 
being implicated in chronic diseases. Some of these 
naturally occurring bioactive substances with antioxidant 
properties, such as plant phenols, vitamins, carotenoids, 
phytoestrogens and terpernoids also have been shown to 





role in disease prevention and immune promotion, 
especially in chronic inflammatory diseases (Weisburger, 
2002). 
Inflammation is a complex process initiated by several 
factors ranging from bacterial infection and chemical 
injury to environmental pollution that result in cell injury or 
death (O’Byrne and Dalgleish, 2001; O’Byrne et al., 
2000). Tissue injury induced by this trauma results in the 
release of inflammatory mediators including the cytokines 
and tumor necrosis factor (TNF-), interleukin-1 (IL-1) 
from leukocytes, monocytes and macrophages (Paterson 
et al., 2003). Saklatvala et al. (2003) reported that the 
cytokines further trigger the up-regulation of other pro-
inflammatory cytokines and chemokines, immunoglobu-
lins, as well as increase the expression of many cellular 
adhesion molecules (CAMs). In other settings the 
phagocytosis of bacteria or foreign particles is associated 
with an increase in oxygen uptake by neutrophils, during 
which large amounts of reactive oxygen species (ROS-) 
such as superoxide anion (O2
-), hydroxyl radical (HO·), 
and hydrogen peroxide (H2O2) are produced (Colin and 
Monteil, 2003). Also, there is an increase in the 
expression of phospholipase A2, 5-lipoxygenase (5-LOX), 
and cyclooxygenase- 2 (COX-2) inducible nitric oxide 
synthase (iNOS) (Nakamura et al., 2003; Okamoto et al., 
2004). ROS- generating enzymes such as NADPH 
oxidase, xanthine oxidase, and myeloperoxidase are 
observed, along with the activation of the transcription 
factor and the nuclear factor kappa B (NFB). Ultimately, 
the activation of the transcription factor NFB appears to 
play a pivotal role in the regulation of inducible enzymes, 
inflammatory cytokines, CAMs, and other substances that 
are initiators or enhancers of the inflammatory process.  
Phytomedicine constituents that inhibit any of the 
above-mentioned molecular targets have the potential to 
inhibit or reduce the inflammatory process, via the mech-
anisms highlighted and reviewed below. Based on these 
observations, several species of medicinal flora of South 
African origin were surveyed and reviewed; their chemi-
cal composition noted and related to their ethnomedical 
uses in the treatment of pain and inflammatory disorders.  
It appears that there is growing interest in anti-
inflammatory activity of plant extracts by Pharmaceutical 
companies as well as the herbal industry. A high 
proportion of the plant species listed here has not been 
examined in detail. 
 
 
A REVIEW OF THE INFLAMMATORY PROCESS 
 
Inflammation is a localized protective reaction of cells/ 
tissues of the body to allergic or chemical irritation, injury 
and/or infections. The symptoms of inflammation are 
characterized by pain, heat, redness, swelling and loss of 
function that result from dilation of the blood vessels 
leading to an increased blood supply and from increased 
intercellular spaces resulting in the movement of leuko- 
cytes,   protein   and   fluids   into   the  inflamed   regions 




(Parham, 2000). Diseases and disorders are manifested 
through inflammatory responses as the body recognises 
the injury and prepare to repair the damage. To 
appreciate the inflammatory process it is important to 
understand the role of chemical mediators. These media-
tors are the substances released as plasma proteins, or 
that come from cells like mast cells, platelets, neutrophils 
and monocytes/macrophages. They are triggered by 
allergic or chemical irritation, injury and infections. These 
mediators, depending on the duration of injury determine 
the severity of inflammation and are termed pro-
inflammatory fundamental factors. These substances 
bind to specific target receptors on the cells and may 
increase vascular permeability, promote neutrophil chem-
otaxis, stimulate smooth muscle contraction, increase 
direct enzymatic activity, induce pain and/or mediate 
oxidative damage (Coleman, 2002). Examples of chemi-
cal mediators include: nitric oxide (NO), prostaglandins 
(PG), leukotrienes (LK), vasoactive amines (histamine, 
serotonin), and cytokines (tumor necrosis factor and 
interleukins–1, 12). Although some of the cytokines (IL-3 
-4,-5,-6,-10,-13) released are beneficial by acting as anti-
inflammatory mediator within the cells (Esch and Stefano, 
2002), these proinflammatory mediators present 
pathways through which disorders in the body may be 
eradicated or ameriolated (Esch and Stefano, 2002).   
Even though the innate cascade process of inflam-
mation is complex, it is mainly divided into two parts i.e. 
acute and chronic which could either be beneficial or 
detrimental. 
 
• Acute inflammation is characterized by rapid onset 
and is of short duration. It is characterised by the 
exudation of fluids and plasma proteins; and the 
migration of leukocytes, most notably neutrophils into 
the injured area. This acute inflammatory response is 
believed to be a defense mechanism aimed at killing 
of bacteria, virus and parasites while still facilitating 
wound repairs.  
• Chronic inflammation is of a more prolonged duration 
and manifests histologically by the presence of 
lymphocytes and macrophages, resulting in fibrosis 
and tissue necrosis. The persistent chronic inflamm-
ation increases the  development of the degenerative  
diseases such as rheumatoid arthritis, atherosclero-
sis, heart disease, Alzheimer, asthma, acquired 
immunodeficiency disorder(AIDS), cancer, conges-
tive heart failure (CHF), multiple sclerosis (MS), 
diabetes, infections (bacteria, fungi, parasites), gout, 
IBD-inflammatory bowel disease, aging and other 
neurodegenerative CNS depression, all of which are 
associated with immunopathological that appears to 
play a key role in the onset of the condition (O’Byrne 
and Dalgleish  2001; Dalgleish and O’Byrne 2002). 
 
These various diseases and disorders have been 
linked to increased expression of pro-inflammatory me-
diators which activates inflammatory  cells  by  increasing 




the expression of pro-inflammatory cytokines, up-regula-
ting genes that produce NF kappa B, NADPH oxidase, 
phospholipase A2, COX-1 and -2, 5-LOX, 
myeloperoxidase, iNOS, increasing oxygen consumption 
and producing many oxygen-free radicals that can finally 
lead to certain degenerative diseases (Giacosa and 
Filiberti, 1996; Vicenzi et al., 1997; Charles et al., 1999; 
Locati and Murphy, 1999). Nitric oxide (NO) is an 
example of reactive species that participates in normal 
physiological processes such as vasodilation and neuro-
transmission; however, overexpression may result in 
disease as observed in inflammation, asthma, cardio-
vascular disorders and organ transplant rejection 
(Coleman, 2002).  Many other factors such as chronic 
lung and liver inflammation caused by tobacco smoking 
and alcohol consumption may lead to lung cancer and 
liver cirrhosis respectively, while the persistent inflamma-
tion of the stomach is caused by the bacterium, 
Helicobacter pylori which may lead to ulcers and 
ultimately to stomach cancer (Farinati et al., 2003). 
In summary, the followings are the main culprits that 
play prominent roles in inflammatory processes:  
 
1. Leukocyte migration (Albelda et al., 1994; Ley, 1996),  
2. NO and Arachidonic acid metabolism (Bennett, 1986; 
Balsinde et al., 2002; Bazan et al., 2002), 
3. Reactive oxygen species (ROS) (Weitzman and 
Gordon 1990, Schreck et al., 1991, DiGiovanni 1992, 
Rosin et al., 1994, Gupta et al., 1999, Schoonbroodt 
and Piette 2000), 
4. NF kappa B (Baldwin 1996, Pahl 1999) and  
5. Pro-inflammatory cytokines (Le and Vilcek, 1987; 
Duff and Durum, 1982; Hirano, 1994; Tracey, 1994; 
Zhao et al., 2003). 
 
Table 1 gives a brief description of the involvement and 




EVIDENCE SHOWING THE INVOLVEMENT OF 
CYTOKINES IN DISEASES 
 
The importance of cytokines in disease has been 
illustrated in studies by Iwalewa and Agbani (2004) and 
Iwalewa et al. (2007) (submitted paper). These studies 
were conducted to inhibit the autacoids released before 
and during malaria infection and diabetes disorders 
respectively. It was found that although indomethacin, p-
chlorophenylalanine (p-CPA), and cyproheptadine all 
block the synthesis of PG, 5-HT, and histamine 
respectively during inflammation, they were only capable 
of mild reduction of the infection in suppressive and 
prophylactic mode of treatment, and had no suppressive 
effect in curative established malaria infection. Bowman 
and Rand (1980) have established that even chloroquine 





apart from its anti-malarial property, possesses anti-
inflammatory activity. Also, in an experiment where 
alloxan was used to induce diabetes in rats, the extract 
Harungana madagascariensis suppressed glucose non-
significantly. From the specific mechanism of action, it 
became clearer that other mediators, more devastating 
than the autacoids are involved in inflammation, which 
has since been identified as the cytokines.  
In another study on Azadirachta indica leaves that 
produced gedunin – a limonoid complemented its anti-
malarial property by reducing inflammatory symptoms of 
pain, pyrexia and swellings and also increasing immuno-
modulatory activities (Bray et al., 1990; Iwalewa et al., 
1999). In addition to being directory pro-inflammatory, the 
cytokines IL-1, 12 are known to induce iNOS and COX-2 
in chronic diseases which further contribute to immune 
complications. The pro-inflammatory cytokines, therefore, 
have to be taken care of in order to overcome completely 
the effect of inflammatory responses. 
 
 
INFLAMMATORY CELLS INVOLVED IN PAIN–
INFLAMMATORY DISORDERS IN VARIOUS ORGANS 
 
The modulations of the various functions of inflammatory 
cells in the body are regulated by pharmacological-
physiological constituents present in herbal products. 
Their actions directly or indirectly affect the immune sys-
tem. The immune system is a highly complex, intricately 
regulated group of cells whose integrated function is 
essential to defend the body from diseases. Cells of the 
immune system may interact in a cell-cell manner and 
may also respond to intercellular messages through the 
transfer of hormones, cytokines, and autacoids elabora-
ted by various cells (Kulmatycki and Jamali, 2005). In the 
CNS, the cells that modulate inflammatory effects are the 
neurons, microglia, astrocytes and endothelial cells 
(Licinio and Wong, 1999) while in the peripheral sites, the 
function of lymphocytes (T cells, B cells, macrophages, 
NK cells) and leukocytes (basophils, monocytes, 
neutrophils, eosinophils), mast cells, and platelets are 
involved. These are described briefly below to expose the 
biochemical markers that constituents of phytomedicines 





In addition to their role in hemostasis and thrombosis, 
considerable evidence implicates platelets as inflamma-
tory cellular elements (Weksler, 1983; Metzger and Page, 
1998). Several pro-inflammatory mediators are derived 
from platelets, including thromboxane A2 and serotonin, 
as well as TGF-b, PDGF, and LOX metabolites, some of 
which are implicated in the pathogenesis of asthma and 
atherogenesis (Metzger and Page, 1998). Platelet activa-
ting factor (PAF)  is  a  well  recognized  pro-inflammatory  




Table 1. The role of Pro-inflammatory (cytokines) mediators as expressed in disease (Kulmatycki and Jamali, 2005). 
 




Increased secretion of TNF-α, IL-1 and IL-6 by macrophages and monocytes 
correlated well with viral load and increased capacity of dendritic cells exposed 
to HIV-1 to produce TNF-α and IL-1β, IL-10 overexpression contributes to B-
cell hyperactivity and risk of AIDS. 
(Emilie and Galanaud 
1998, Locati and Murphy 
1999, Lore et al., 1999, 
Lee and Montaner 1999)   
Acute Infection Elevated myeloperoxidase, ROS and IL-6 in severe infections served as an 
index in viral and bacterial causes  
(Kulander et al., 2001)   
Parasitic Infections Increased TNF-α concentrations in patients with Plasmodium falciparum 
malaria is associated with pathogenesis of disease  
(Odeh 2001). 
Asthma Promotion of eosinophilia and cytokines that regulate allergic states and 
production of IL-4, IL-5, IL-10 and IL-13 were associated with asthma; 
administration of IL-12, IFN-α/γ are suggested to alleviate asthma disease; 
increased NO in exhaled air reflected airway inflammation in asthma patients. 
(Bellanti, 1998., 
Romagnani  2000,  
Silvestri et al., 2003).  
Cancer Increases IL-6 and IL-6sR are associated with progression and metastasis of 
prostate cancer  




Atherosclerosis CRP is a strong predictor for future coronary events in healthy individuals; 
increased endothelium concentrations of IL-1 and TNF-inducible adhesion 
molecules P-selectin, E-selectin, VCAM-1 and intracellular adhesion molecule 
(ICAM)-1 in atherosclerotic tissue; high density lipoproteins may protect 
against coronary artery disease by inhibition of adhesion molecules; high 
density lipoproteins are suggest to inhibit TNF-α and IL-1β from increasing 
expression of E-selectin, VCAM-1 and ICAM-1; endothelial dysfunction is 
associated with altered NO bioavailability due to either reduced formation or 
accelerated degradation; CRP levels predicted future risk of coronary heart 
disease in healthy middle-aged men; CRP suggested to have a fundamental 
role in atherogenesis . 
(Cockerill et al., 1999., 
Libby et al., 2002, Rifai 
and Ridker 2002). 
Congestive Heart 
Failure 
Increased concentrations of TNF-α and IL-6 were associated with progression 
from asymptomatic to symptomatic left ventricular dysfunction and excessive 
TNF-α levels associated with mortality; IL-6 is a strong predictor of disease 
progression; patients without cachexia that experience acute decompensation 
have increased levels of TNF-α. 
(Milani. et al., 1996, 
Tsutamoto et al 1998, 
Torre-Amione 2000, Mann  
2002). 
Elderly (Aging) Elevated concentrations of IL-1, TNF-α, IL-6 and sTNFRII increased 
concentrations of TNF-α independent of atherosclerosis; elevated 
concentrations of IL-6 and CRP predicted disability onset; increased 
concentrations of CRP and IL-6 were associated with mortality; increased CRP 
concentrations in the elderly was associated with development of diabetes 
mellitus; after challenge with endotoxin aging was associated with more rapid 
increase in CRP and prolonged inflammatory response and fever compared to 
younger individuals; high levels of TNF-α were associated with high 
prevalence of atherosclerosis  
(Liao  et al., 1993, 
Bruunsgaard  et al 1999, 
Barzilay et al., 2001, 
Krabbe et al., 2001). 
Fever In periphery and brain increased concentrations of IL-1α, 1β, TNF-α and IL-6; 
post-myocardial infarction patients with prolonged fever had increased 
inflammatory activity. 
(Zetterstrom  et al., 1998, 




Crohn’s Disease High IL-1 and 12 activity increases pro-inflammatory state.  (van Hogezand  et al., 
1998). 
Peptic Ulcer High ulcerogenic potential of Helicobacter pylori is linked, in part, to increased 
activity of IL-8 and TNF-α; Helicobacter pylori and NSAIDs cause ulcer 
recurrence through production of IL-1 and TNF-α by macrophages 
accumulated at the ulcer scar. 
(Lehmann  and Stalder, 
















Neuroinflammation due to inflammatory mediator overexpression is 
associated with behavioral disturbances; increased IL-1 expression in 
Alzheimer brain is directly related to plaque formation and progression 
and neuronal overexpression of acetylcholinesterase; TNF-α, IL-1β and 
IL-6 overexpression stimulated production of amyloid-β which is crucial for 
neurodegeneration in Alzheimer’s patients. 
(Griffin  et al., 1998, Mrak and Griffin  
2001, Eikelenboom  et al., 2002, 




Overexpression of IL-1 in middle-aged individuals that have concurrent 
Alzheimer-type changes and in young and fetal Down’s patients. 
(Griffin et al., 1998) 
Multiple 
Sclerosis 
Elevated TNF-α concentrations in serum and cerebral spinal fluid; brain 
endothelium and astrocytes increased expression of ICAM-1.  
(Ledeen and Chakraborty 1998, 
Lenercept  1999, Munoz-Fernandez 
and Fresno 1998) 
Diabetes Th-1 and Th-2 cells and their respective mediators participate and 
cooperate in inducing and sustaining pancreatic islet cell -cell destruction 
in insulin dependent diabetes; inflammation important factor in 
pathogenesis of diabetes and metabolic disorders in women; increased 
CRP levels suggested to predict development of type 2 diabetes; obesity 
and diabetes inflammatory states in which mediators of inflammation 
contribute to insulin resistance. 
(Almawi  et al., 1998, Han et al., 2002, 
Dandona  et al., 2004, Sjöholm and 
Nyström 2005) 
Pain TNF-α, IL-1 and IL-6 pathway is associated with altered pain perception; 
hyperalgesia induced by TNF-α via stimulating release of IL-1; 
hyperalgesia induced by peripheral inflammation is associated with IL-1 
overexpression; spinal cord glia and glially derived proinflammatory 
cytokines suggested to be powerful modulators of pain; interleukin-1β 
mediated induction of cyclooxygenase-2 in neurons of the central nervous 
system contributes to inflammatory pain hypersensitivity; bradykinin B2 
receptors are suggested to be involved with the acute phase of the 
inflammatory and pain response; TNF-α expression is suggested to be 
upregulated in Schwann cells influencing central in painful neuropathies. 
(Watkins  and Maier, 1995, Watkins  
et al., 1999, Samad et al 2001, 
Couture  et al 2001, Empl  et al., 
2001, Rutowski and DeLeo 2002, De 





Depression Increased expression of IL-1β, IL-6 and IFN-γ, IL-1ra, sIL-6r and TNF-α; 
increased IL-1β concentrations in cerebrospinal fluid; increased 
concentrations of IL-6, sIL-6r, sIL-2r and transferrin receptor in major 
depression. 
(Maes  et al., 1995, Connor  and 
Leonard, 1998, Levine  et al., 1999) 
Schizophrenia Increased concentrations of IL-6 and TNF-α increased IL-1β 
polymorphism; drug-naïve schizophernic patients had increased IL-2 and 
IFN-γ production compared to controls. 
(Naudin  et al., 1996, Monteleone  et 
al., 1997, Frommberger  et al.,1997, 
Katila  et al., 1999, Cazzullo et al., 
2001). 
Sleep disorders TNF-α and IL-6 suggested to play an important role in mediating 
sleepiness and fatigue in disorders of excessive daytime sleepiness; 
systemic inflammatory response and reduced plasma availability of 
tryptophan was related to primary sleep disorders and major depression. 
(Vgontzas  et al., 1997, Song  et al., 
1998). 
Stress Psychological stress is associated with increased production of TNF-α, IL-
1, IL-1ra, IFN-γ and lower production of IL-4 and IL-10; increased 
expression of neutrophils, monocytes, CD8+, CD2+CD26+ and CD2+HLA-
DR+ T cells and CD19+ B cells; post traumatic stress disorder was 
associated with increased IL-6 signaling . 
(Maes  et al., 1998, 1999a 1999b) 
Rheumatoid 
Arthritis 
Increased concentrations of TNF-α as a central proinflammatory mediator 
increased concentrations of IL-1, IL-6, TNF-α, GM-CSF, and chemokines 
IL-8.  
(Odeh 1997, Feldman  et al.,  1996,  
1998, Charles et al., 1999) 
Sepsis Systemic inflammatory response syndrome due to pro-inflammatory 
mediator excess is associated with severe inflammatory responses then 
excessive anti-inflammatory responses possibly leading to increased 
susceptibility to infection; septic shock is caused at least in part by 
excessive or deregulated host inflammatory responses. 
(van der Poll and van Deventer  1999, 







mediator derived from membrane phospholipids by the 
enzymatic activity of phospholipase A2 and an acetyl 
transferase in mast cells, basophils, eosinophils, and 
endothelial cells. PAF receptor-coupled activation of 
phosphoinositide-specific phospholipase C and phospho-
rylation of several cellular proteins has been reported.  
 
 
Neutrophils/ macrophages/monocytes  
 
Oxygen free radicals and non-radical reactive oxygen 
intermediates released by neutrophils and other phagocy-
tes have been increasingly implicated in inflammatory/ 
immune disorders (Fantone and Ward, 1982; Ward et al., 
1991). This may be accomplished by interference with 
NADPH oxidase, a powerful oxidant- producing enzyme 
localized on the surface membrane of neutrophils 
(Tauber et al., 1984).  
 
 
Mast cells and basophils 
 
Mast cells play a central role in the pathogenesis of 
diseases such as allergic asthma, rhino-conjunctivitis, 
urticaria, anaphylaxis, and systemic mastocytosis; they 
may also be important players in other chronic inflamma-
tory disorders such as inflammatory bowel disease and 
rheumatoid arthritis (Galli, 1993; Theoharides, 1996). 
Mast cells may also participate in sterile inflammatory 
conditions exacerbated by stress, such as atopic derma-
titis, interstitial cystitis, irritable bowel syndrome, 
migraines, and multiple sclerosis (Theoharides, 1996). 
Basophils, the circulating “equivalent” of the tissue mast 
cells, are now considered as important cells in the 
pathogenesis of late phase allergic reactions (Lemanske 
and Kaliner, 1988; Grant and Li, 1998). Both cells are 
known to produce histamine. 
 
 
NF-kappa B, TNF-alpha, IFN-gamma 
 
NF kappaB (NFB) is a (complex of proteins) transcrip-
tion factor that binds to DNA and activates gene 
transcription (Baldwin, 1996). The expression of many 
proteins, including all pro-inflammatory cytokines, chemo-
kines, and enzymes of the arachidonic acid cascade, are 
regulated by the transcription factor NFB (Pahl, 1999). 
In normal cells, NFB is bound to an inhibitory protein 
IB, and the complex IkappaB is present in the cyto-
plasm. A variety of inflammatory stimuli, such as bacterial 
infections, lipopolysaccharide (LPS), injury, TPA, UV 
irradiation, ROS, and inflammatory cytokines (TNF and 
IL-1), activate NFB by phosphorylating I-kappaB with 
IB kinase and subsequently degrading the IB complex. 
Released NFB is then translocated into the nucleus and 
binds to DNA and activates the transcription of many 
genes, including pro-inflammatory cytokines, chemo-
kines, TNF, IL-1, adhesion molecules, phospholipids A2,  




lipoxygenase, COX-2, iNOS, and myeloperoxidase 
(Baldwin, 1996; Pahl, 1999). Abnormal activation of the 
NFB pathway is involved in degenerative chronic 
inflammatory diseases, such as asthma, rheumatoid 
arthritis, inflammatory bowel disease, artherosclerosis, 
and Alzheimer’s disease (Podolsky, 1991; Ross, 1993; 
Tak and Firestein, 2001; Collins and Cybulsky, 2001). 
 
 
Lymphocytes (T and B cells) 
 
T lymphocyte stimulation through the antigen receptor 
causes early activation of a tyrosine kinase (Samelson et 
al., 1986; Patel et al., 1987; Trevillyan et al., 1990) and 
the generation of phosphatidylinositol (PI) biphosphate 
(PIP2)-derived second messengers, namely inositol 
triphosphare (IP3) and diacyl glycerol (DAG), via activa-
tion of phospholipase C (Koretzky et al., 1990; Ledbetter 
et al., 1991). Several cellular substrates are phosphory-
lated through the activation of protein kinase PTK, this 
eventually lead to the expression of IL-1. It is now 
understood that the proliferative signal is generated by 
members of a family of PTKs that catalyze the 
phosphorylation of cellular substrates, which in turn leads 
to T cell proliferation (Rudd, 1990). B lymphocyte 
activation, like T cell activation, is accompanied by 
phosphorylation of tyrosine on particular B cell proteins 
(Campbell and Sefton, 1990; Gold et al., 1990; Lane et 
al., 1991; Yamanashi et al., 1991). Uckun et al., (1991) in 
human B cell studies, showed that IL-7 receptor ligation 
with recombinant human IL-7 caused increased phospho-
rylation on tyrosine of multiple substrate proteins, 
stimulated phosphatidylinositol turnover  with increased 
IP3 generation (PLC activation), and also DNA synthesis. 
 
 
INVOLVEMENT AND INTERACTION BETWEEN 
NITRIC OXIDE AND PROSTAGLANDIN 
BIOSYNTHESIS IN INFLAMMATORY DISORDERS 
 
The biosynthesis and release of nitric oxide (NO) and 
prostaglandins (PGs) share a number of similarities. 
Three major forms of nitric-oxide synthase (constitutive, 
inducible and endothelial NOS) and cyclooxygenase 
(COX) enzymes have been identified to date. Under 
normal circumstances, the constitutive isoforms of these 
enzymes (NOS and COX-1) are found in virtually all 
organs. Their presence accounts for the regulation of 
several important physiological effects (e.g. antiplatelet 
activity, vasodilation, and cytoprotection). On the other 
hand, in an inflammatory setting, the more inducible 
isoforms of these enzymes (inducible NOS and COX-2) 
are detected in a variety of cells, resulting in the 
production of large amounts of pro-inflammatory and 
cytotoxic NO and PGs. These substances play an 
important role in injured tissues by enhancing the blood 
flow to the area to promote healing. Unfortunately, the 
release of NO and PGs by the inducible isoforms  of  NOs  




and COX has been associated with the pathological roles 
of these mediators in disease states as evidenced by the 
use of selective inhibitors. An important link between the 
NOS and COX pathways has been identified. Salvemini 
et al. (1993) demonstrated that the enhanced release of 
PGs, which follows inflammatory mechanisms, was nearly 
entirely driven by NO. Such studies raised the possibility 
that COX enzymes represent important endogenous 
"receptor" targets for modulating the multifaceted roles of 
NO. Furthermore, other studies have highlighted the 
importance of such interaction in physiology as well as in 
the mechanism of action of drugs such as organic 
nitrates. More importantly, mechanistic studies of how NO 
switches on/off the PG/COX pathway have been 
undertaken and additional pathways through which NO 
modulates prostaglandin production unraveled. On the 
other hand, NO donors conjugated with COX inhibitors 
have recently found new interest in the understanding of 
NO/COX reciprocal interaction and potential clinical use 
(Mollace et al., 2005). 
 
 
PHYTOMEDICINES (HERBAL MEDICINE) AGAINST 
PAIN-INFLAMMATORY DISORDERS IN VARIOUS 
ORGANS 
 
Based on the molecular events that lead to inflammation, 
we therefore suggest that the process of sustained 
inflammation that accompanies chronic diseases can be 
ameliorated and possibly even prevented by phytomedi-
cines. The anti-inflammatory properties of several 
phytomedicines origin, that contain substances like 
phytoestrogens, flavonoids and its derivatives, phytoste-
rol, tocopherol, ascorbic acid, curcumin, genistein, and 
others can be the inhibitors of the molecular targets of 
pro-inflammatory mediators in inflammatory responses. 
There are other plants that contain alkaloids, tannin, 
saponins, anthraquinones, triterpenoids and other consti-
tuents which have been reported to possess a diverse 
range of bioactivities including anticancer, immunostimu-
latory, antibacterial, antimalarial and antituberculosis 
activities bearing in mind that some of the causative 
organisms and factors responsible for the initiating and 
promoting inflammation could be remove or neutralised to 
suppress the expression of pro-inflammatory agents. All 
these are reviewed and discussed below.  
The ancient African healers possessed numerous 
recipes in the form of herbs, minerals and animal parts 
used as remedies in disease conditions. The list was 
however, dominated by food plants with the belief that 
“food is medicine and medicine is food” (Etkins and Ross, 
1983; Iwu 1993). Incidentally, some of the recipes cited 
for inflammatory and pain disorders in South African flora 
were also cited by Iwu (1993) with similar indications. 
This is pointing to the fact that African traditional 






The southern African floral heritage has been des-
cribed as among the most diverse in the world (Arnold 
and De Wet, 1993; Germishuizen and Meyer, 2003). The 
flora potential and the remarkable cultural systems 
pertaining to the use of herbal remedies to treat both 
animals and human diseases provides the information 
and opportunities for a scientific validation of acclaimed 
efficacy of these medicinal plants. The treatment of 
livestock diseases using traditional remedies is widely 
practiced in the rural communities. In the Eastern Cape 
Province, it is estimated that more than 75% of small 
scale farmers and dwellers use herbal remedies for their 
livestock (Masika et al., 2000). However, for medicinal 
plants used in the treatment of inflammatory-pain 
disorders, more than 115 plant species of 60 families are 
used as sources of therapies (Table 2). The evidence 
pointing to the fact that these flora are used for pain-
inflammatory disorders arose from the various indications 
that emanated from ethnomedicinal surveys and the 
diverse arrays of chemical constituents found in these 
plants.  
Some of the plants are employed to treat diabetes, 
tumors, stomach pain, rheumatism and many other 
indications (Watts and Breyer-Brandwijk, 1962; Hutchings 
et al., 1996). Jäger et al. (1996) also screened 39 Zulu 
medicinal plants for prostaglandin-synthesis inhibitors out 
of which two-thirds of the plants possessed high prosta-
glandin inhibitory activity. Another interesting feature of 
herbal remedies is the wide variety of conditions that is 
said to be treatable with a single plant or group of plants. 
The reasons why some remedies from plants are used 
for so many indications could be that they affect a 
common (denominator) factor responsible for the 
diseases and disorders as shown in Table 1. For exam-
ple, a decoction from the stem bark extract of a plant 
could relief pain symptoms, abdominal cramp, fever, 
swelling, induce sleep, treat dysentery and diarrhoea, 
alleviate respiratory discomfort, cold and infections of 
various kinds. If one considers that the body reaction to 
all this diseases is standard - inflammatory, a plant 
effective against a variety of non–related diseases could 
just be inflammatory. This leads to speculation that infla-
mmation may be the basis underlining many diseases 
and bodily disorders.  
The changes observed in various functions of 
inflammatory cells in the body are regulated by 
pharmacological/physiological constituents present in 
herbal products. Therefore, the biochemical markers in 
inflammatory processes help to expose the pathways 
involved in diseases, which the constituents of 
phytomedicines might inhibit (Figure 1).  In South Africa 
however, the choice of a plant material being used for 
pain – inflammatory disorder among the Zulus, Sotho and 
Xhosa is based on the name given to the plant, its 
frequency of usage of the same plant and for the same 
biological activities (Watts and Breyer-Brandwijk, 1962; 
Hutchings et al., 1996). 























• HIV/AIDS, Malaria 
• Fever 
• Rheumatoid arthritis 
• Gout 
• Multiple sclerosis 








inhibit/block the activities 






















Figure 1. The sketch diagram shows the pathways of tissue damage and inflammatory diseases and disorders. Site *1 
indicate the presence of mast cells, leukocytes (basophils, monocytes, neutrophils, eosinophils) and platelets that release 
5-HT, histamine, PG- especially the COX-1, ROS in acute inflammatory stage. Site *2 shows the presence of platelets, 
lymphocytes (T cells, B cells, macrophages, NK cells), that release more devastating pro-inflammatory cytokines like IL-1, 




Knowledge has been built for decades on the use of 
herbal medicinal products and extracts in the treatment of 
human diseases. We believe that parallel knowledge can 
be used for treating animal diseases and in fact there is a 
parallel body of knowledge on the use of medicinal plants 
in treating various animal diseases. This is applied to 
increase the quality of life of livestock and rural dwellers. 
One of the main factors militating against animal 
production in the rural communities in Southern Africa is 
infection of their livestock and infections from bacteria 
(including tuberculosis), fungi, viruses, worms and other 
parasites are sources of inflammatory disease. Some of 
the plants used by the Zulus, Sotho and Xhosa for pain – 
inflammatory disorder include Terminalia (Combretaceae) 
of different species, Athrixia phylicoides (Asteraceae), 
Peltophorum africanum (Fabaceae), Sclerocarya birrea 
(Anacardiaceae), Acacia sieberiana (Fabaceae) and 
some of these have been evaluated for their antibacterial, 
antifungal, anthelmintic, antioxidant and anti-inflammatory 
activities (Martini and Eloff, 1998; Eloff ,1999; McGaw et 
al., 2001; Eloff, 2001; Eloff et al, 2001; Kotze and Eloff, 
2002; Martini et al., 2004a, b; Katerere and Eloff, 2004; 
Naidoo et al., 2004). These are some of the factors/ 
mechanisms through which inflammatory disorders are 
expressed in both animals and humans where these 
plant species are used. These factors that could trigger 
the release of mediators in inflammatory responses, we 
believe must be removed to ensure healthy conditions for 
both humans and animals. Other mechanisms are 
highlighted below.  
Other prominent plants of southern African origin 
include Sutherlandia frutescens (Fabaceae), which 
contains canavanine non-protein free amino acids from 
the leaves, seeds, stem, flowers and fruits (Van Wyk et 
al., 1997; Katerere and Eloff, 2005), Cyrtanthus 
suaveolens, Gethyllis ciliaris and other species that 
belong to the family, Amaryllidaceae. These are known to 
contain alkaloids (Elgorashi and van Staden, 2004), 
which are of great importance in CNS inflammation in 
their neuroprotective activity (Suk, 2005). Other groups of  




plants that affect the immune system (immunomodulatory 
/immunoprotective) are Pelargonium sidoides, and 
Picrorhiza scrophularriflora (Scrophulariaceae) (Van der 
Walt and Vorster, 1988). Table 2, however, show the list 




CONSTITUENTS IN MEDICINAL PLANTS CAPABLE 
OF INHIBITING PRO-INFLAMMATORY MEDIATORS  
 
The following plant secondary metabolites are capable of 
modifying the activities of inflammatory cells: flavonoids, 
triterpenoids, sterols (phytosterols), tannins, alkaloids, 
chalcone, anthraquinone, sesquitertepenoids, curcumin, 
coumarins, polyphenolic compounds, carotenes, vitamins 
A, E and C, limonoids, essential and volatile oils. 
 
 
General inhibitory pathways of inflammation by 
phytomedicinal constituents  
 
The general mechanism of actions of phytomedicines are 
classified into 4 basic groups:  
 
1. Immunoprotective/immunomodulatory properties, 
2. Inhibition of NFB, NO, COX and ROS generation, 
3. Inhibition of enzymes- tyrosine, and 
4. Preventing the entry of microorganism (membrane 
stabilizing properties). 
 
The immune system can be modified by diet, pharmaco-
logical agents, and naturally occurring food chemicals, 
such as vitamins and flavonoids. Plants contain a wide 
variety of natural compounds mainly plant secondary 
compounds. Among the secondary compounds are the 
flavonoids (Martins et al., 2007). Flavonoids are among 
the most common constituents in plants. They are 
present in high concentrations in flowers, seeds, leaves, 
herbs, fruits, stems, bulbs, tea, wine, vegetables and 
other food sources (Middleton et al., 2000). Over 4000 
structural unique flavonoids have been identified in plants 
(Harborne et al., 1975; Harborne, 1986). They are non-
steroidal natural phenolic compounds that exhibit likely or 
similar activities related to synthetic non-steroidal anti-
inflammatory drugs (NSAID) used in inflammatory-pain 
disorders. It is evident that the flavonoids display, to a 
variable extent, a remarkable array of biochemical and 
pharmacological actions which suggest that certain 
members of this group of compounds significantly affect 
the function of the immune system and inflammatory cells 
(Middleton and Kandaswami, 1992). Several flavonoids 
specifically affect the function of enzyme systems 
critically involved in the generation of inflammatory pro-
cesses, especially tyrosine (Nishizuka, 1988; Hunter, 
1995) and serine-threonine protein kinases. Recently, it 





involved in signal transduction and cell activation pro-
cesses involving cells of the immune system, as well as 
other cells activated by hormones, autocoids, neurotrans-
mitters, and growth factors (Dangoria et al., 1996; 
Querbes et al., 2004). In addition, some constituents are 
free radical scavengers (Cos et al., 1998) and are 
therefore able to reduce tissue damage caused by 
oxidation stress of superoxide, hydroxyl and lipid peroxi-
dation products. Green tea polyphenols, curcumin, and 
resveratrol inhibit the activation of NFB and also have 
antioxidant activity (Nakamura et al., 1998; Shishodia et 
al., 2003). They are considered as moderate anti-
inflammatory agents and could be used for preventive 
therapy and perhaps as therapeutics for the treatment of 
inflammation related diseases (Yamamoto and Gaynor, 
2001). This particular action prevents microorganisms 
from gaining entry into cells especially during infections. 
Cell membrane stabilizing properties of the constituents 
would however come into play.  
In another dimension, NFB plays a critical role in the 
regulation of genes involved in the expression of pro-
inflammatory enzymes (iNOS, COX-1 and 2, TNF-), 
suppression of NFB in its binding capacity to DNA by 
constituents of phytomedicine are likely to reduced the 
expression of nitric oxide and prostaglandin enzymes 
(Kim et al., 2005). As mentioned in Table 2, several 
herbal extracts of South African origin contain compli-
cated mixtures of organic chemicals, including fatty acids, 
sterols, alkaloids, flavonoids, glycosides, saponins, 
tannins, and terpenes. Flavonoids are not the only com-
ponent possessing anti-inflammatory effects, alkaloids 
detected in Amaryllidaceous species and other plants 
have been well demonstrated to significantly improve the 
impairment of learning, short-term and spatial memory 
through the inhibition of acetylcholinesterase in the CNS 
(Woodruff-Pak et al., 2001; Sweeney et al., 1990). Some 
of the plants found in this region for inflammatory 
conditions contain high concentrations of saponins, which 
has antioxidant activity (Metodiewa and Koska, 2000).  
The role of pro-inflammatory cytokines in inflammation 
cannot be over-emphasized. Through the immunomodu-
latory and immunoprotective effects immune systems can 
be stimulated (up-regulation), suppressed (down-
regulated) or restored by plant products and this is the 
most logical intervention in inflammatory therapies. This 
is because the cytokines and NFB are the devastating 
products from cells that generate all other factors in 
inflammatory process. For example Pelargonium 
sidoides, and the Picrorhiza scrophularriflora (Scrophula-
riaceae) (Van der Walt and Vorster ,1988) are native of 
the coastal regions of South Africa are used for acute 
bronchitis and tonsillopharyngitis, and contain coumarins 
phenolic compounds and tannins. Immunomodulatory 
properties were demonstrated by tannins and coumarins 
which were mediated through NO, TNF-, IL, and NK-
cells inhibition (Koch et al., 2002). Several plant-derived 
natural products that possess immunomodulatory effects  




Table 2. List of plant species and their families, constituents/isolated compounds, various indications and parts used in pain-inflammatory 
disorders (Watts and Breyer-Brandwijk, 1962; Hutchings et al., 1996). 
 
Plant species (family) Parts used Constituents Indications 
Acacia burkei (Fabaceae) stem bark / root  not known painful back and eye 
Acacia sieberiana (Fabaceae) stem bark not known fever, genitals and back pains 
and aches  
Achyranthes aspera 
(Amaranthaceae) 
whole plant: root, 
leaves and aerial 
parts 
achyranthine and glycosides chest pain, coughs, menstrual 
bleeding, boils, abscesses and 
stomach complaints.  
Acokanthera oppositifolia 
(Apocynaceae) 
leaves and root amorphous acokantherin painful feet, rheumatism, 
toothache, abnormal menstrual 
period, and swellings 
Alepidea amatymbica 
(Apiaceae) 
root/rhizome terpenoid kaurene cold, cough, diarrhoea, 
headache and rheumatism 
Aptenia cordifolia 
(Mesembryanthemaceae) 
leaves and stem alkaloids painful joints. 
Asclepias fruiticosa 
(Asclepiadaceae) 
leaf, stem and root aardenolide glycoside diarrhoea and stomach pain, 




root and leaves diterpenoids cough , sores and boils  
Barleria ovata (Acanthaceae) root not known painful nodule swellings under 
the skin  
Berchemia zeyheri 
(Rhamnaceae) 
stem bark pentahydroxychachones backache and rectal ulcer 
Berkheya speciosa  
(Asteraceae) 
root and leaves  sesquiterpenoids, socomene abdominal pains  
Bidens pilosa (Asteraceae)  root and leaves chalchones and polyacetylenes jaundice, eye, colic, bronchial 
problems, and rheumatism 
Boophane disticha 
(Amaryllidaceae) 
bulb alkaloids headache, chest and bladder 
pain, boils wounds and swelling.  
Bowiea volubilis (Liliaceae) bulb cardiac glycosides facilitate child-birth, bladder 




 leaves mucilage, tannins and onopordopicrin. facilitate child-birth, back and 
stomach pain, pneumonia. 
Bridelia micrantha 
(Euphorbiaceae) 
root, stem bark and 
leaf 
friedelin, epi-friedelin, gallic acid, 
anthocyanidin, taraxerol, taraxerone and 
caffeic acid 
lung pain, cough, diabetes, 
epigastric pain, toothache and 
fever. 
Bulbine alooides (Liliaceae) tuber not known anti-syphilis and rheumatism 
Bulbine asphodeloides 
(Liliaceae) 
tuber and leaves not known rashes, sores wounds, 
dysentery and diarrhoea 
Bulbine latifolia (Liliaceae) leaves not known dysentery and diarrhoea 
Capparis tomentosa 
(Capparaceae) 
root bark sulphur oil swellingsand fever 
Cavacoa aurea 
(Euphorbiaceae) 
root not known pain and fever  
Cenchrus ciliaris (Poaceae) rhizome not known body pain, menstrual disorders 
and urinary infections in women  
Cephalaria zeyheriana 
(Dipsaceae) 
root decoction not known swellings andpain  
Chaetacme aristata 
(Ulmaceae) 
bark and root not known swellings in haemorrhoids and 
dental anodynes 
Clausena anisata (Rutaceae) leaves, stem and 
root 
terpenoids, alkaloids, coumarins and 
limonoids 
abdominal pain toothache fever 
and rheumatism 
 










not known intestinal worms, cough, fever, painful sore 
throat, fracture joints, and rheumatism   
Clutia spp (Euphorbiaceae)  leaf not known painful joints, back and rheumatism 




whole plant hydrocyanic acid sore eye and throat ailment, malaria, sooth 
urethral pains.  
Cotyledon orbiculata 
(Crassulaceae) 
leaf and sap tyledoside and bufanolides earache, toothache and boil  






triterpenoids and flavonoids. 
painful joints, backache,  rheumatism, 
sores and swellings 
Crinum moorei (Amaryllidaceae) bulb and 
leaves 
lycorine, cheryrilline, crinamidine swellings and growth 
Croton gratissimus 
(Euphorbiaceae) 
stem bark not known inhaled to relieve pain. 
Croton steenkampianus 
(Euphorbiaceae) 
leaf not known painful joints, back and rheumatism 
Croton sylvaticus 
(Euphorbiaceae)  
stem bark tannin abdominal and uterine disorders and fever  
Cryptocarya lantifolia 
(Lauraceae) 
stem bark not known internal and uterine pains, muscular 
cramps   
Cucumis africanus 
(Cucurbitaceae) 
fruits and leaf curcumin relieve of lumbago 
Cycnium racemosum 
(Scrophulariaceae) 
root not known painful eposodes in pregnancy. 
Cyrtanthus suaveolens  + spp    
(Amaryllidaceae) 
bulb, root and 
leaves 
alkaloids, triterpenoids and 
flavonoids. 










root triterpenoids -amyrim, -
sitosterol, alkaloids and saponin 
abdominal pains,   diarrhea, coughs, 
bacterial infections. 
Diospyros villosa (Ebenaceae) root and leaf not known painful fractures and intestinal complaints. 
Dovyalis rhamnoides 
(Flacourtiaceae) 
root and bark not known painful joints, and rheumatism 




stem bark alkaloids and protease inhibitors swellings, abscesses and growth 
Erythrophleum lasianthum 
(Fabaceae)  
stem bark erythrophleine persistent body pain and intestinal spasm. 
Euclea natalensis (Ebenaceae) root bark pentacyclic terpenoids swellings and growth 
Eucomis autumnalis (Liliaceae) bulb homoisoflavones, nortriterpenes, 
eucosterol 




bulb and root homoisoflavones, nortriterpenes, 
eucosterol 
rheumatism and teething baby 
Euphorbia bupleurifolia 
(Euphorbiaceae) 
root not known swellings on the lower limbs and cancer. 
Euphorbia ingens 
(Euphorbiaceae) 




latex/root resin swellings on the lower limbs 
Foeniculum vulgare (Apiaceae) leaves and 
stem 
quercetin derivatives, volatile oil menstrual pains, jaundice, diarrhoea, 
cramp and diuretics  




Table 2. Contd. 
 
Gethyllis ciliaris (Amaryllidaceae) fruit pods, 
leaves and  
flower 
not known colic, flatulent, indigestion, stomach 
disorders, and toothache. 
Gnida kraussiana 
(Thymelaeceae) 
root and flower 
parts 
 
flavone, painful joints, backache, bronchitis, 
coughs, boil, fever and  rheumatism   
Graderia scabra 
(Scrophulariaceae) 
leaves and root not known fever and stomach trouble 
Gunnera perpensa 
(Gunneraceae) 
root bitter principles cancerous sores, facilitates child-birth, 




root and stem 
bark  
not known, acne, skin problems and fractures 
Helichrysum nudifolium 
(Asteraceae) 




root scyllitol, tannins, saponin. painful joints and backache   
Heteromorpha trifoliata 
(Apiaceae) 
leaves and root falcarindiol and sarisan mental disturbances, headache, 
asthma, coughs, painful joints and 
backache.  
Hibiscus aethiopicus (Malvaceae) root not known painful swollen  joints, and heart burn  




leaf not known swellings and growth 
Kigelia africana (Bignoniaceae) dried fruit/bark luteolin, flavonoids isocoumarins, 
sterols and iridoid glycosides. 
painful joints, back and rheumatism 
Ledebouria ovatifolia (Liliaceae) bulb not known gastro-enteritis, backache  
Ledebouria revoluta (Liliaceae) bulb not known skin irritation, wounds and sores 
Leonotis leonurus (Laminaceae) leaves and 
stem bark 
phenolic compounds, resins and 
carotenoid 
feverish headache, dysentery, coughs 
and colds and haemorrhoids. 
Linum thunbergii (Linaceae) root  not known pain 
Lippia javanica (Verbenaceae) leaf, stem and 
root 
pentacyclic triterpenoids, essential 
oil, amino acids, stearic and other 
acids 
painful cough and cold, fever, chest 
pain, weak joints, back and 
rheumatism 
Manilkara concolor (Sapotaceae) root not known painful joints, back and rheumatism 
Melia azadirach (Meliaceae) leaves, stem 
root seed and 
friut 
triterpenoids and steroids, 
limonoids, gedunin, coumarins, 
flavonoids 








leaves not known swollen feet , stomach ailment 
Ochna serrulata (Ochnaceae) root not known gangrenous rectitis  
Ocotea bullata (Lauraceae)   bark tannins urinary pains  and headache 
Peltophorum africanum 
(Fabaceae) 
root and stem 
bark 
flavonoids, gallic and chlorogenic 
acid 
colic, cough, painful tooth,  joints, 
backaches and fever 
Pentanisia prunelloides 
(Rubiaceae) 
root, leaves not known haemorroids, rheumatism, abdominal 




fruit root and 
leaves 




stem bark saponins painful back, fever, stomach, chest 
and abdominal pains. 












root chromocoumarins and fritinone facilitates child-birth, chronic ulcer, 
gonorrhoea. 
Printzia pyrifolia  
(Asteraceae)  
root  coumarate abortion and stomach ache. 
Protorhus longifolia 
(Anacardiaceae) 
bark tannins heart burn and stomach bleeding 
Prunus africana (Rosaceae) bark and fruits amygdalin, friedelin, hydrocyanic , 
ursolic acids, sterols 
intercostal-pain, prostrate hypertropy. 
Ptaeroxylon obliqum 
(Ptaeroxylaceae) 
bark and root essential oil, resin, saponin, 
pyrogallol, tannins flavone and 
alkaloids. 








 leaves/ whole 
part 
terpenoids derivatives and 
flavonoids 
cold and vagina tumor 
Rapanea melanophloeos 
(Myrsinaceae) 
bark and root tannin, triterpenoids saponin ulcer, stomach pain and fever 
Raphinonacme spp 
(Periplocaceae) 
root not known chronic ulcer, backache and uterine pain 
Rhus chirindensis 
(Anacardiaceae) 
stem bark not known heart and mental complaints, and 
rheumatism  
Rothmannia capensis 
(Rubiaceae)   
fruit and root not known painful burns, wounds and rheumatism  
Rubus rigidus + spp 
(Rosaceae) 
root tannins, pyragallol diarrhoea and  dysentery, toothache, 
coughs and colds. 
Sarcophyte sanguinea 
(Balanophoraceae) 
whole plant exocarpic acid , naringenin, amenorrhoea, dysentery,and diarrhoea and 
swellings growth 
Scilla natalensis (Liliaceae) bulb saponin facilitate child-birth, sprains and fractures.  
Scilla nervosa (Liliaceae) bulb digitalis dysentery and rheumatism fever 
Sclerocarya birrea 
(Anacardiaceae) 
root, leaves and 
stem bark 
tannins, trace alkaloids, vitamin c, 
flavonoids 
malaria fever, diarrhoea, painful joints, 
backache, menorrhagia and stomach 
disorders. 
Secamone gerardii  
(Asclepiadaceae) 
root not known painful chest, and spinal disorders  
Senecio speciosus 
(Asteraceae)  
stem and leaves not known chest pain and headache 
Solanum spp (Solanaceae) root, fruits 
leaves and stem 
bark. 
alkaloids, vitamin c, carotene painful abdominal upset, toothache, ulcers, 
coughs asthma, rheumatism and swellings 
Stapelia gigantea 
(Asclepiadaceae) 
stem bark anthraquinones painful body and limbs  
Strychnos henningsii 
(Loganiaceae) 




seed, leaf, stem, 
flower and fruit. 
canavanine and free amino-acids cancer, gastric ailment, gynaecological 




bark flavonols, alkaloids and tannins fever, diarrhea and dysentery, pains 
sleeplessness, stomach and chest pains  
Terminalia phanerophlebia 
(Combretaceae) 
root bark triterpenoids, tannin, nerifolin and 
sericoside 
diarrhoea and colic  
Terminalia sericae 
(Combretaceae) 
root bark triterpenoids, tannin, nerifolin and 
sericoside 
diarrhoea and colic  
 








leaves diterpenoids coughs and sore throat, malaria fever. 




tannin and resins rheumatism, stomach andintestinal pains 
Tulbaghia violacea  
(Alliaceae) 
tuber alkyl cystine sulfoxides, flavones, 
flavonols, steroidal saponin 















glaucolides fever. painful joints, back and chest, and 
rheumatism 
Viscum spp (Viscaceae) whole plant or 
milk infusion 
 mistletoe lectin i 
 
painful menstruation, asthma, bronchitis, stomach 




leaf infusion not known body pains and as tonic 
Warburgia salutaris 
(Canellaceae) 





tropanol, steroidal lactones, 
alkaloids 
swellings, painful joints,  rheumatism, fever, 









bark and root 





have been reviewed (Wagner, 1990). These plants 
especially the Echinaceae species contain alkaloids, 
quinones, terpenoids, phenolcarboxylic acid, polysaccha-
rides and glycoproteins. Apart from these constituents, -
sitosterols have been revealed to also possess 





Rheumatoid arthritis, asthma and diabetes (just to 
mention a few) are chronic diseases generally associated 
with immunological chaos. The introduction of molecular 
biological models and new target-directed pharmacologi-
cal screening procedures (Wagner, 1999) in 
phytomedicine, research is a way to supply new 
information and to reveal the underlying mechanism of 
action of herbal medicinal products. The understanding of 
how chronic inflammation is responsible for various 
disease states supports studies to provide therapeutic 
remedies with target sites the cytokines, induced iNOS, 
COX-2, NFB, and other enzymes. 
The molecular mechanism of anti-inflammatory 
phytomedicine shares common molecular targets with 
nonsteroidal anti-inflammatory drugs, as well as steroidal 
drugs. Both nonsteroidal anti-inflammatory drugs and 
phytomedicine constituents such as sterols, alkaloids, 
flavonoids, glycosides, saponins, tannins, and terpenes 
-tocopherol, ascorbic acid, curcumin, [salicylic acid 
derivatives] etc. are able to inhibit processes that lead to 
inflammation, such as (1) the activation of NFB (2) 
induction and up-regulation of pro-inflammatory cyto-
kines, (3) up-regulation and activation of CAMs by pro-
inflammatory cytokine TNF- and inflammatory media-
tors, (4) up-regulation of arachidonic acid metabolites by 
increasing its metabolism, and (5) production of ROS. 
Because inflammation is a complex, innate response that 
is triggered by tissue insult due to infection, toxin, trauma, 
post-ischemia, and autoimmune injury, the recovery from 
this process normally occurs during healing. However, if 
tissue destruction and assisted repair are not properly 
directed, inflammation can lead to persistent tissue 
damage in the CNS, through the neurons, microglia, 
astrocytes and endothelia cells, while in the peripheral 
sites, the function of lymphocytes (T cells, B cells, 
macrophages, NK cells) and leukocytes (basophils, 
monocytes, neutrophils, eosinophils), mast cells, platelets 
and collagen are involved. Such persistent inflammation 
may lead to certain chronic diseases and the inhibition of 
one or more of the complex chain reactions noted above 
may arrest this inflammatory process, thereby preventing 
chronic diseases. Therefore, it is worth evaluating the use 
of phytomedicines that have an effect on NFB as 
potential agents of preventing inflammation and thus 
chronic diseases.  
In approximately one third of the plant species listed in  




Table 2 there is no indication of the chemical compounds 
present.  In many other cases the chemicals present are 
based on group tests and only on rare cases have the 
active compounds been isolated and characterized. This 
opens up an important field for the application of 
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